Drug Trial Radar · NCT07363694
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Last checked: Nov 19, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,156
Planned (sponsor's estimate)
Start
Feb 11, 2026
Primary completion
Oct 24, 2030
Study completion Jan 16, 2031
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jan 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 35 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 35 to 80 years old * Have had moderate-to-severe COPD for at least 12 months * Have a documented history of at least 2 moderate or severe exacerbations within the last 12 months * Have been continuously taking their regular maintenance treatment(s) for COPD over at least 6 months at a stable dose for 3 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 24 weeks for the Phase 2 part and 52 weeks for the Phase 3 part. We will compare the results of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants who will be involved in the Phase 2 part of the study for about 40 weeks. During this time, they will have 11 visits at the study clinic. Participants who will be involved in the Phase 3 part of the study for about 68 weeks. During this time, they will have 18 visits at the study clinic.
Conditions
- Moderate to Severe Chronic Obstructive Pulmonary Disease
Interventions
PF-07275315 dose 1Drug
SC injection dose 1
PF-07275315-dose 2Drug
SC injection dose 2
PlaceboDrug
SC injection matched
PF-07275315-dose 3Drug
SC injection dose 3
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase 2 part: Change from baseline in pre-bronchodilator Forced Expiratory Volume in 1 Second (FEV1) at Week 24Time frame: Baseline to Week 24
- Phase 3 part: Annualized rate of moderate or severe ECOPDTime frame: Baseline to Week 52
Locations
189 sites in 18 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Lung Health Center
Birmingham, Alabama · Recruiting
SEC Clinical Research
Dothan, Alabama · Recruiting
Pulmonary Associates of Mobile, P.C.
Mobile, Alabama · Recruiting
Pulmonary Associates, PA
Phoenix, Arizona · Recruiting
IMAX Clinical Trials
La Palma, California · Recruiting
NewportNativeMD, Inc.
Newport Beach, California · Recruiting
California Medical Research Associates
Northridge, California · Recruiting
Institute of HealthCare Assessment d/b/a Apex Clinical Research
San Diego, California · Recruiting
Finlay Medical Research
Greenacres City, Florida · Recruiting
Clinical Research Specialists LLC
Kissimmee, Florida · Recruiting
Advanced Pulmonary Research Institute
Loxahatchee Groves, Florida · Recruiting
Reed Medical Research
Miami, Florida · Recruiting
Renstar Medical Research
Ocala, Florida · Recruiting
HCA Florida Ocala Imaging Center
Ocala, Florida · Recruiting
Ocala Lung and Critical Care Associates
Ocala, Florida · Recruiting
Renstar Medical Research
Ocala, Florida · Recruiting
Coastal Medical Research Institute, LLC
St. Petersburg, Florida · Recruiting
Coastal Pulmonary and Critical Care, P.L.C
St. Petersburg, Florida · Recruiting
Clinical Research Trials of Florida, Inc.
Tampa, Florida · Recruiting
Clinical Site Partners, LLC dba Flourish Research
Winter Park, Florida · Recruiting
Cpcc-Research Llc
East Point, Georgia · Recruiting
Centricity Research Rincon Pulmonology
Rincon, Georgia · Recruiting
ASHA Clinical Research - Munster, LLC
Hammond, Indiana · Recruiting
Methodist Hospital Southlake
Merrillville, Indiana · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
Southern Clinical Research, LLC
Zachary, Louisiana · Recruiting
Paul A. Shapero, MD, PA
Bangor, Maine · Not yet recruiting
Exordia Medical Research Inc.
Fall River, Massachusetts · Recruiting
Infinity Medical Research
North Dartmouth, Massachusetts · Recruiting
Revival Research Institute, LLC
Dearborn, Michigan · Recruiting
AA Medical Research Center
Flint, Michigan · Recruiting
Revive Research Institute, Inc.
Southfield, Michigan · Recruiting
Oakland Medical Research
Troy, Michigan · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Barnes-Jewish Hospital Investigational Drug Service
St Louis, Missouri · Recruiting
Barnes-Jewish Hospital
St Louis, Missouri · Recruiting
Washington University School of Medicine
St Louis, Missouri · Recruiting
Washington University School-Cardiovascular Imaging and Clinical Research Core Laboratory
St Louis, Missouri · Recruiting
Henderson Clinical Trials
Henderson, Nevada · Recruiting
Northwell Health Physician Partners at Chappaqua
Chappaqua, New York · Not yet recruiting
Showing 40 of 189 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.